COMPANY NEWS
Worldwide spinal implants industry to 2026 – by implant type, type, end-users and geography
The spinal implants market is expected to grow at a compound annual growth rate of 3.57% over the forecast period to reach a market size of US$15,304.985 million in 2026 from US$11,983.748 million in
DIPLOMAT® – Posterior Instrumentation
Promotional feature To provide an optimal patient treatment the demands placed on a pedicle screw system are very high – regardless of the particular indication. Both simple and complex spine
CERCCESS – Cervical retractor system
Both simple and complex treatments of the cervical spine require not only the highest degree of safety but also a comfortable and absolutely reliable instrument set. CERCCESSTM combines all these
NuVasive and the International Spine Study Group Foundation announce expanded long-term partnership with initiation of additional clinical studies
NuVasive, a spine technology innovation company, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, and the International Spine Study Group Foundation (ISSGF) recently announced the continuation of
Mainstay Medical announces commercial launch of ReActiv8 in Australia
Mainstay Medical Holdings recently announced the commercial launch in Australia of ReActiv8®, its implantable neurostimulation system to treat chronic low back pain. “Launching ReActiv8, our Restorative Neurostimulation therapy, commercially in Australia
MedTech start-up, Axis Spine Technologies, completes £2.2m funding round led by ACF Investors
Axis Spine Technologies Ltd (AST) has raised £2.2m in a funding round led by ACF Investors, with follow-on investment from Mercia’s EIS funds. Mercia was the first investor when Axis
Sacrix develops new iteration of SacroFuse for sacroiliac joint support
Sacrix has developed the third iteration of the SacroFuse threaded compression device for immediate stabilisation of the sacroiliac joint for pain relief and ultimately fusion
RABEA by SIGNUS – gold standard in anterior cervical fusion
Promotional feature RABEA® SIGNUS developed the first plan-parallel fusion cage worldwide. RABEA® received CE approval in 1996 and is, more than 25 years later, still gold standard in anterior
ST-Line – Next in fusion
Promotional feature With its new ST-Line, SIGNUS has applied the progress from endoprosthetic research to spinal surgery Regardless of the application, the excellent mechanical and biological properties of titanium and
